Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma

Chinese Medical Journal

Volumn 111, Issue 8, 1998, Pages 751-753

  Xue, Hongli ^a   Wang, Hui ^a   Kong, Lingquan ^a   Zhou, Huaiwei ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; NITROSOUREA DERIVATIVE; PAPAVERINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD BRAIN BARRIER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CAROTID ARTERY; CLINICAL TRIAL; DRUG EFFECT; DRUG INDICATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CAROTID ARTERY, INTERNAL; CHILD; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHOTREXATE; MIDDLE AGED; PAPAVERINE; VASODILATOR AGENTS;

EID: 7344248990     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Xue HL., Primary report of treatment of malignant glioma by intracarotid infusion of BCNU. J Apoplexy Nerv Dis 1989; 6:46.
2. Li MW, Tang WY. The clinical significance of reversible opening of the blood brain barrier in the chemotherapy of brain tumor. Chin J Neurosurg 1992; 8:14.
3. Neuwelt EA, Frenkel EP, Diehl J, et al. Reversible osmotic blood-brain-barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. Neurosurgery 1980; 7:44.
4. Nir I, Levanon D, Iosilevsky GD. Permeability of blood vessels in experimental glioma: uptake of 99m Tc-Glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy. Neurosurgery 1989; 25:523.
5. Groothuis DR, Fischer JM, Lapin G, et al. Permeability of different experimental brain tumor models of horseradish peroxidase. J Neuropathol Exp Neurol 1982; 41:164.
6. Duan HP, Duan GS, Zhang J, et al. Ultra-selective intraarterial chemotherapy in the treatment of glioma. Chin J Neurosurg 1990; 6: 244.
7. Johnson DW, Parkinson D, Wolpert SM, et al. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 1987; 20:577.
8. Gumerlock MK, Belshe BD, Madsen R, et al. Osmotic bloodbrain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review. J Neurooncol 1992; 12:33.
9. Harsh GR, Levin AL, Gutin PH, et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987; 21:615.
10. Ammirati M, Galicich JH, Arbit E, et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neuroaurgery 1987; 21:607.
11. Watne K, Hannisdal E, Nome O, et al. Combined intraarterial and systemic chemotherapy for recurrent malignant brain tumors. Neurosurgery 1992; 30:223.
12. Samuel H. Intraoperative radiation therapy. Kyoto: CRC Press, 1989:125.